Literature DB >> 32423739

Microbiota and cancer: host cellular mechanisms activated by gut microbial metabolites.

Sofia A Tsvetikova1, Elena I Koshel2.   

Abstract

In recent years, more and more data indicate the effect of human microbiota on carcinogenesis. Despite the numerous studies on the relationship between gut microbiota and carcinogenesis, the exact mechanisms of this interaction are not well studied. It becomes apparent that this relationship can be mediated by microbial metabolites. Mechanisms of some well-known bacterial genotoxins and oncogenes, such as colibactin, CagA, IpgD, VirA, P37, have been studied in detail. At the same time, a role in carcinogenesis of a large group of gut microbial metabolites, including short-chain fatty acids, polyamines, and products of polyphenol and tryptophan catabolism, is less well understood. However, more and more evidence data show the effect of bacterial metabolites on cancer development and progression. In this review, we summarize relevant data regarding the possible mechanisms that can account for the effects of gut microbial metabolites mentioned above in carcinogenesis.
Copyright © 2020 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  bacterial metabolites; cancer; gut microbiota; microbiota-host interaction

Year:  2020        PMID: 32423739     DOI: 10.1016/j.ijmm.2020.151425

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  12 in total

Review 1.  Exploiting dietary fibre and the gut microbiota in pelvic radiotherapy patients.

Authors:  Selina E Eaton; Justyna Kaczmarek; Daanish Mahmood; Anna M McDiarmid; Alya N Norarfan; Erin G Scott; Chee Kin Then; Hailey Y Tsui; Anne E Kiltie
Journal:  Br J Cancer       Date:  2022-09-29       Impact factor: 9.075

Review 2.  Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.

Authors:  Hourieh Sadrekarimi; Zhanna R Gardanova; Morteza Bakhshesh; Farnoosh Ebrahimzadeh; Amirhossein Fakhre Yaseri; Lakshmi Thangavelu; Zahra Hasanpoor; Firoozeh Abolhasani Zadeh; Mohammad Saeed Kahrizi
Journal:  J Transl Med       Date:  2022-07-06       Impact factor: 8.440

Review 3.  Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects.

Authors:  Jing Li; Ai-Hua Zhang; Fang-Fang Wu; Xi-Jun Wang
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

4.  Dysbiosis of skin microbiome and gut microbiome in melanoma progression.

Authors:  Chahrazed Mekadim; Helena Kupcova Skalnikova; Jana Cizkova; Veronika Cizkova; Anna Palanova; Vratislav Horak; Jakub Mrazek
Journal:  BMC Microbiol       Date:  2022-02-25       Impact factor: 3.605

Review 5.  Microbiota medicine: towards clinical revolution.

Authors:  Prisca Gebrayel; Carole Nicco; Souhaila Al Khodor; Jaroslaw Bilinski; Elisabetta Caselli; Elena M Comelli; Markus Egert; Cristina Giaroni; Tomasz M Karpinski; Igor Loniewski; Agata Mulak; Julie Reygner; Paulina Samczuk; Matteo Serino; Mariusz Sikora; Annalisa Terranegra; Marcin Ufnal; Romain Villeger; Chantal Pichon; Peter Konturek; Marvin Edeas
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 6.  Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy.

Authors:  Kayla Jaye; Dennis Chang; Chun Guang Li; Deep Jyoti Bhuyan
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

7.  Microbiome Profile of Dogs with Stage IV Multicentric Lymphoma: A Pilot Study.

Authors:  Feriel Yasmine Mahiddine; Inhwan You; Heekee Park; Min Jung Kim
Journal:  Vet Sci       Date:  2022-08-04

8.  Gut microbiota in women with gestational diabetes mellitus has potential impact on metabolism in pregnant mice and their offspring.

Authors:  Shengtang Qin; Yutong Wang; Shuxian Wang; Bohan Ning; Jing Huai; Huixia Yang
Journal:  Front Microbiol       Date:  2022-08-05       Impact factor: 6.064

9.  Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC.

Authors:  Kousik Kesh; Roberto Mendez; Beatriz Mateo-Victoriano; Vanessa T Garrido; Brittany Durden; Vineet K Gupta; Alfredo Oliveras Reyes; Nipun Merchant; Jashodeep Datta; Santanu Banerjee; Sulagna Banerjee
Journal:  Gut Microbes       Date:  2022 Jan-Dec

10.  Dietary Correlates of Oral and Gut Microbiota in the Water Monitor Lizard, Varanus salvator (Laurenti, 1768).

Authors:  Yu Du; Jun-Qiong Chen; Qian Liu; Jian-Chao Fu; Chi-Xian Lin; Long-Hui Lin; Hong Li; Yan-Fu Qu; Xiang Ji
Journal:  Front Microbiol       Date:  2022-01-06       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.